Renaissance Technologies - FULCRUM THERAPEUTICS INC ownership

FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 102 filers reported holding FULCRUM THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of FULCRUM THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$82,193
+35025.2%
13,257
-74.9%
0.00%
Q3 2023$234
-79.4%
52,734
-84.7%
0.00%
-100.0%
Q2 2023$1,138
+2.3%
344,810
-11.6%
0.00%
+100.0%
Q1 2023$1,112
-99.7%
390,100
+473.7%
0.00%
Q2 2022$333,000
-91.2%
68,000
-49.2%
0.00%
-100.0%
Q3 2021$3,777,000133,9000.01%
Other shareholders
FULCRUM THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
TRV GP III, LLC 3,962,202$70,091,00017.54%
TRV GP IV, LLC 2,343,154$41,450,00011.92%
ACUTA CAPITAL PARTNERS, LLC 200,000$3,538,0001.49%
HighVista Strategies LLC 89,963$1,591,0001.27%
Logos Global Management LP 685,000$12,118,0001.25%
Monashee Investment Management LLC 273,045$4,830,0001.19%
RTW INVESTMENTS, LP 3,866,872$68,405,0001.00%
Parkman Healthcare Partners LLC 250,106$4,424,0000.98%
Deep Track Capital, LP 750,000$13,268,0000.94%
Darwin Global Management, Ltd. 317,428$5,615,0000.86%
View complete list of FULCRUM THERAPEUTICS INC shareholders